Altintas Dogan et al 75 experiment found that liraglutide significantly reduced body weight, decreased inflammatory markers such as IL-6 and MCP-1, increased exertional spirometry (FVC) and carbon monoxide diffusion capacity, and improved COPD assessment test scores, but no significant improvement in FEV1, FEV1/FVC, or 6-minute walk tests, suggesting the possibility that GLP-1RA may reduce inflammatory responses, improve lung function, and mitigate the degree of impaired health in patients with COPD
The answer is yesif your current dose is producing results and you tolerate it well, your provider may recommend maintaining that level rather than advancing further
Communicating awareness to a healthcare provider is essential, especially if symptoms persist or become severe
In case a higher dose is required and recommended by your provider throughout your program, you can take advantage of our high dose membership program as follows: Tirzepatide: For most states, our high dose membership offers up to 15mg/week (as medically appropriate) for an additional $150 per month
Semaglutide is a glucagon-like peptide-1 receptor agonist, modeling the activity of a natural hormone called glucagon-like peptide-1